CA2319446A1 - Radiopaque implantable collagenous biomaterial device - Google Patents

Radiopaque implantable collagenous biomaterial device Download PDF

Info

Publication number
CA2319446A1
CA2319446A1 CA002319446A CA2319446A CA2319446A1 CA 2319446 A1 CA2319446 A1 CA 2319446A1 CA 002319446 A CA002319446 A CA 002319446A CA 2319446 A CA2319446 A CA 2319446A CA 2319446 A1 CA2319446 A1 CA 2319446A1
Authority
CA
Canada
Prior art keywords
submucosa
implantable biomaterial
biomaterial
implantable
radiopaque marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002319446A
Other languages
French (fr)
Other versions
CA2319446C (en
Inventor
Mark W. Bleyer
Michael C. Hiles
Umesh H. Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Biotech Inc
Original Assignee
Cook Biotech, Inc.
Mark W. Bleyer
Michael C. Hiles
Umesh H. Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Biotech, Inc., Mark W. Bleyer, Michael C. Hiles, Umesh H. Patel filed Critical Cook Biotech, Inc.
Publication of CA2319446A1 publication Critical patent/CA2319446A1/en
Application granted granted Critical
Publication of CA2319446C publication Critical patent/CA2319446C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers

Abstract

Disclosed is a medical device. Specifically, a radiopaque implantable biomaterial device is provided. In one aspect, the device comprises a collagenous biomaterial derived from tissue submucosa having a biotropic agent, the biotropic agent comprising at least one of a proteoglycan, growth factor, glycoprotein, or glycosaminoglycan disposed thereon; and a radiopaque marker disposed on the collagenous biomaterial.

Claims (35)

1. A radiopaque implantable biomaterial (5) device, comprising:
a collagenous biomaterial (10) having a biotropic agent (11), the biotropic agent (11) comprising at least one of a proteoglycan, growth factor, glycoprotein, and glycosaminoglycan disposed thereon; and a radiopaque marker (16) disposed on the collagenous biomaterial (10).
2. The implantable biomaterial device (5) of claim 1 wherein the collagenous biomaterial (10) comprises tissue submucosa.
3. The implantable biomaterial device (5) of claim 2 wherein the tissue submucosa (10) comprises at least one of a porcine, bovine, and ovine submucosa.
4. The implantable biomaterial device (5) of claim 3 wherein the tissue submucosa (10) further comprises the submucosa from at least one of an alimentary, genital, urinary, respiratory, and integumentary submucosa.
5. The implantable biomaterial device (5) of claim 1 further comprising a pharmacologic agent (22) disposed on the collagenous biomaterial (10).
6. The implantable biomaterial device (5) of claim 1 wherein the radiopaque marker (16) further comprises at least one of tantalum, barium, iodine, and bismuth, and a derivative thereof.
7. The implantable biomaterial device (5) of claim 1 wherein the radiopaque marker (16) is disposed on a serosal side (18) of a tissue submucosa (10).
8. The implantable biomaterial device (5) of claim 7 wherein the radiopaque marker (16) comprises tantalum.
9. The implantable biomaterial device (5) of claim 1 wherein the radiopaque marker (16) comprises at least one of barium sulphate, iodine, and bismuth oxychloride (16).
10. The implantable biomaterial device (5) of claim 1 wherein the radiopaque marker (16) is disposed on a tissue submucosa (10).
11. The implantable biomaterial device (5) of claim 10 wherein the tissue submucosa (10) comprises a warm blooded vertebrate submucosa.
12. The implantable biomaterial device (5) of claim 11 wherein the tissue submucosa (10) comprises warm blooded vertebrate submucosa from at least one of an alimentary, genital, urinary, respiratory, and integumentary submucosa.
13. The implantable biomaterial device (5) of claim 1 wherein the collagenous biomaterial (10) comprises a collagenous biocompatible biomaterial.
14. The implantable biomaterial device (5) of claim 13 wherein the radiomarker (16) comprises tantalum powder and the collagenous biomaterial (10) comprises a warm blooded vertebrate submucosa from at least one of an alimentary, genital, urinary, respiratory, and integumentary submucosa.
15. The implantable biomaterial device (5) of claim 14 wherein the biomaterial (10) has at least one of coiled, helical, spring-like, randomized, branched, sheet-like, tubular, spherical, and fragmented shape (13).
16. The implantable biomaterial device (5) of claim 15 wherein the biomaterial (10) comprises at least one of a fluidized, comminuted, liquefied, suspended, gel-like, injectable, powdered, ground, sheared, and solid shape (13).
17. The implantable biomaterial device (5) of claim 16 further comprising an injectable (13), coiled (13), biocompatible collagenous biomaterial (10) having a tantalum powder radiopaque marker (16) disposed thereon.
18. The implantable biomaterial device (5) of claim 1 wherein the device comprises at least one of coiled, helical, spring-like, randomized, branched, sheet-like, tubular, spherical, and fragmented shape (13).
19. A radiopaque implantable biomaterial device (5), comprising:
a warm blooded vertebrate tissue submucosa (10); and a radiopaque marker (16) disposed on the tissue submucosa (10).
20. The implantable biomaterial device (5) of claim 19 wherein the warm blooded vertebrate submucosa (10) comprises at least one of bovine, porcine, and ovine submucosa (10).
21. The implantable biomaterial device (5) of claim 20 wherein the tissue submucosa (10) further comprises the submucosa (10) from at least one of an alimentary, genital, urinary, respiratory, and integumentary submucosa (10).
22. The implantable biomaterial device (5) of claim 21 wherein the tissue submucosa (10) further comprises a pharmacologic agent (22) disposed on the tissue submucosa (10).
23. The implantable biomaterial device (5) of claim 19 wherein the radiopaque marker (16) comprises at least one of tantalum, barium, iodine, and bismuth, and derivative thereof.
24. The implantable biomaterial device (5) of claim 23 wherein the radiopaque marker (16) comprises tantalum powder.
25. The implantable biomaterial device (5) of claim 23 wherein the radiopaque marker (16) comprises at least one of barium sulphate, iodine, and bismuth oxychloride.
26. The implantable biomaterial device (5) of claim 19 further comprising a porcine alimentary submucosa (12) including a tantalum powder radiopaque marker (16) disposed thereon.
27. The implantable biomaterial device (5) of claim 19 wherein the device has at least one of a coiled, helical, spring-like, randomized, branched, sheet-like, tubular, spherical, and fragmented shape (13).
28. The implantable biomaterial device (5) of claim 19 wherein the material comprises at least one of in the shape (13) of fluidized, comminuted, liquefied, suspended, gel-like, injectable, powdered, ground, sheared, and solid.
29. The implantable biomaterial device (5) of claim 19 wherein the device comprises a biocompatible tissue submucosa (10).
30. The implantable biomaterial device (5) of claim 29 wherein the device has an endotoxin level less than 12 endotoxin units per gram.
31. The implantable biomaterial device (5) of claim 19 wherein the device further comprises:
porcine tissue submucosa (10);

a tantalum radiopaque marker (16) disposed on the submucosa (10); and having an endotoxin level less than 12 endotoxin units per gram.
32. A radiopaque implantable biomaterial device (5), comprising:
a warm blooded vertebrate submucosa (10) from at least one of an alimentary, genital, urinary, respiratory, and integumentary submucosa;
the submucosa (10) shaped into a coil (28); and a tantalum powder radiopaque marker (16) disposed on the submucosa (10).
33. The implantable biomaterial device (5) of claim 32 wherein the device comprises a biocompatible submucosa (10).
34. The implantable biomaterial device (5) of claim 33 wherein the device has an endotoxin level less than 12 endotoxin units per gram.
35. The implantable biomaterial device (5) of claim 34 wherein the device comprises a pharmacologic agent (22) disposed on the submucosa (10).
CA2319446A 1998-12-01 1999-11-22 Radiopaque implantable collagenous biomaterial device Expired - Fee Related CA2319446C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11040798P 1998-12-01 1998-12-01
US60/110,407 1998-12-01
PCT/US1999/027652 WO2000032253A1 (en) 1998-12-01 1999-11-22 Radiopaque implantable collagenous biomaterial device

Publications (2)

Publication Number Publication Date
CA2319446A1 true CA2319446A1 (en) 2000-06-08
CA2319446C CA2319446C (en) 2010-09-14

Family

ID=22332849

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002319443A Expired - Lifetime CA2319443C (en) 1998-12-01 1999-05-27 Collagenous biomaterials formed with submucosal tissue
CA2319446A Expired - Fee Related CA2319446C (en) 1998-12-01 1999-11-22 Radiopaque implantable collagenous biomaterial device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002319443A Expired - Lifetime CA2319443C (en) 1998-12-01 1999-05-27 Collagenous biomaterials formed with submucosal tissue

Country Status (10)

Country Link
US (2) US7713552B2 (en)
EP (3) EP1985320B1 (en)
JP (1) JP2002531181A (en)
AT (1) ATE301478T1 (en)
AU (2) AU4316399A (en)
BR (1) BR9908043A (en)
CA (2) CA2319443C (en)
DE (2) DE69939370D1 (en)
DK (1) DK1051206T3 (en)
WO (2) WO2000032250A1 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
ES2208974T3 (en) 1996-08-23 2004-06-16 Cook Biotech, Inc. PROTESIS OF GRAFT, MATERIALS AND METHODS.
US6270464B1 (en) * 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US8882850B2 (en) 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
CA2452040C (en) 2001-06-29 2011-03-22 Cook Biotech Incorporated Porous sponge matrix medical devices and methods
EP1416874A4 (en) * 2001-07-16 2007-04-18 Depuy Products Inc Hybrid biologic/synthetic porous extracellular matrix scaffolds
WO2003007789A2 (en) * 2001-07-16 2003-01-30 Depuy Products, Inc. Porous extracellular matrix scaffold and method
JP2005523733A (en) * 2001-07-16 2005-08-11 デピュイ・プロダクツ・インコーポレイテッド Porous delivery support framework material and method
JP4180509B2 (en) 2001-07-26 2008-11-12 ウイルソンークック メディカル インク． Vessel occlusion member and distribution device thereof
US8465516B2 (en) 2001-07-26 2013-06-18 Oregon Health Science University Bodily lumen closure apparatus and method
US7744651B2 (en) 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
JP2006515765A (en) 2002-11-15 2006-06-08 エスディージーアイ・ホールディングス・インコーポレーテッド Collagen-based materials and methods for treating synovial joints
WO2005077433A1 (en) 2004-02-09 2005-08-25 Cook Biotech Incorporated Stent graft devices having collagen coating
AU2005231781A1 (en) * 2004-03-31 2005-10-20 Cook Incorporated ECM-based graft material
CA2575240A1 (en) * 2004-07-30 2006-02-09 Cook Biotech Incorporated Graft with increased resistance to enzymatic degradation
US7387604B2 (en) * 2004-11-03 2008-06-17 Cook Incorporated Methods for treating valve-associated regions of vascular vessels
US20060206139A1 (en) * 2005-01-19 2006-09-14 Tekulve Kurt J Vascular occlusion device
US20060270911A1 (en) * 2005-04-08 2006-11-30 Voegele James W Tissue retraction device
US9788821B2 (en) 2005-04-29 2017-10-17 Cook Biotech Incorporated Physically modified extracellular matrix materials and uses thereof
CN1903143A (en) 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 Biological type artificial blood vessel and method for preparing the same
CN1903144A (en) 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 Biological artificial ligamentum and method for preparing same
CN100482178C (en) 2005-08-04 2009-04-29 广东冠昊生物科技有限公司 Blood vessel tumor clip with biological film
CA2626460A1 (en) * 2005-10-18 2007-04-26 Organogenesis, Inc. Antimicrobial collagenous constructs
CN1986001B (en) 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 Biological wound-protecting film
CN1986006A (en) 2005-12-20 2007-06-27 广州知光生物科技有限公司 Biological nerve duct
US8357085B2 (en) 2009-03-31 2013-01-22 Ethicon Endo-Surgery, Inc. Devices and methods for providing access into a body cavity
EP2043531B1 (en) 2006-06-15 2013-01-02 Cook Medical Technologies LLC Systems and devices for the delivery of endoluminal prostheses
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8029532B2 (en) * 2006-10-11 2011-10-04 Cook Medical Technologies Llc Closure device with biomaterial patches
US8617205B2 (en) 2007-02-01 2013-12-31 Cook Medical Technologies Llc Closure device
WO2008094706A2 (en) 2007-02-01 2008-08-07 Cook Incorporated Closure device and method of closing a bodily opening
WO2008094691A2 (en) * 2007-02-01 2008-08-07 Cook Incorporated Closure device and method for occluding a bodily passageway
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US8025495B2 (en) 2007-08-27 2011-09-27 Cook Medical Technologies Llc Apparatus and method for making a spider occlusion device
US8734483B2 (en) 2007-08-27 2014-05-27 Cook Medical Technologies Llc Spider PFO closure device
US8308752B2 (en) * 2007-08-27 2012-11-13 Cook Medical Technologies Llc Barrel occlusion device
US8029560B2 (en) 2007-09-12 2011-10-04 Cook Medical Technologies Llc Enhanced remodelable materials for occluding bodily vessels
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
CA2728240C (en) * 2008-06-10 2016-11-15 Cook Biotech Incorporated Quilted implantable graft
EP2307071B1 (en) * 2008-06-20 2015-08-12 Cook Biotech Incorporated Composite extracellular matrix materials and medical products formed therefrom
US9150318B1 (en) 2009-01-02 2015-10-06 Lifecell Corporation Method for sterilizing an acellular tissue matrix
WO2010088678A2 (en) * 2009-02-02 2010-08-05 Cook Biotech Incorporated Medical bead products
CA2752899A1 (en) * 2009-02-18 2010-08-26 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US9737334B2 (en) 2009-03-06 2017-08-22 Ethicon Llc Methods and devices for accessing a body cavity
US8353824B2 (en) 2009-03-31 2013-01-15 Ethicon Endo-Surgery, Inc. Access method with insert
US20100249521A1 (en) 2009-03-31 2010-09-30 Shelton Iv Frederick E Access Device Including Retractor And Insert
US20110028793A1 (en) * 2009-07-30 2011-02-03 Ethicon Endo-Surgery, Inc. Methods and devices for providing access into a body cavity
US9474540B2 (en) 2009-10-08 2016-10-25 Ethicon-Endo-Surgery, Inc. Laparoscopic device with compound angulation
US8518064B2 (en) * 2009-12-17 2013-08-27 Cook Medical Technologies Llc Method for anchoring occlusion plug
US8562592B2 (en) 2010-05-07 2013-10-22 Ethicon Endo-Surgery, Inc. Compound angle laparoscopic methods and devices
US9226760B2 (en) 2010-05-07 2016-01-05 Ethicon Endo-Surgery, Inc. Laparoscopic devices with flexible actuation mechanisms
US8460337B2 (en) 2010-06-09 2013-06-11 Ethicon Endo-Surgery, Inc. Selectable handle biasing
EP2627265B8 (en) 2010-10-15 2019-02-20 Cook Medical Technologies LLC Occlusion device for blocking fluid flow through bodily passages
AU2012262549B2 (en) 2011-05-27 2016-02-11 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
US9233015B2 (en) 2012-06-15 2016-01-12 Trivascular, Inc. Endovascular delivery system with an improved radiopaque marker scheme
AU2014214700B2 (en) 2013-02-11 2018-01-18 Cook Medical Technologies Llc Expandable support frame and medical device
KR20180100586A (en) 2015-12-23 2018-09-11 로드아일랜드하스피틀 Heat accelerator composition and method of use
CA3055551A1 (en) 2017-03-06 2018-09-13 Tei Biosciences, Inc. Perforated tissue graft
EP3693030A1 (en) 2019-02-07 2020-08-12 P+F Products + Features GmbH Method for preparing biological tissue for surgical implantation

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US2172903A (en) 1937-09-24 1939-09-12 Paul M Charping Electric lighting system
US3336918A (en) * 1962-12-24 1967-08-22 Us Catheter & Instr Corp Radiopaque, urethane-coated catheter and method for coating same
AT261800B (en) 1966-08-22 1968-05-10 Braun Internat Gmbh B Process for the manufacture of tubular, smooth or threaded tissue-blood vessel prostheses
US3810473A (en) * 1972-12-04 1974-05-14 Avicon Inc Liquid-laid, non-woven, fibrous collagen derived surgical web having hemostatic and wound sealing properties
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
AU4798785A (en) * 1984-10-03 1986-04-10 Baylor College Of Medicine Implant rupture mammography
US4629458A (en) * 1985-02-26 1986-12-16 Cordis Corporation Reinforcing structure for cardiovascular graft
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
JPH01158963A (en) * 1987-12-17 1989-06-22 Terumo Corp Collagen matrix containing cell growth factor
JP2610471B2 (en) * 1988-03-09 1997-05-14 テルモ 株式会社 Cell-invasive medical material and method for producing the same
US5219576A (en) * 1988-06-30 1993-06-15 Collagen Corporation Collagen wound healing matrices and process for their production
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
DE3831657A1 (en) * 1988-09-17 1990-03-22 Boehringer Ingelheim Kg DEVICE FOR THE OSTEOSYNTHESIS AND METHOD FOR THE PRODUCTION THEREOF
US5141747A (en) * 1989-05-23 1992-08-25 Minnesota Mining And Manufacturing Company Denatured collagen membrane
IT216721Z2 (en) * 1989-06-30 1991-09-19 Euroresearch S R L Milano TUTOR CONSTITUTED BY A HETEROLOGICAL COLLAGEN TUBULAR, SUITABLE FOR USE IN THE SUTURE OF CABLE ORGANS.
US5298222A (en) * 1989-08-09 1994-03-29 Osteotech, Inc. Process for disinfecting musculoskeletal tissue and tissues prepared thereby
US5108421A (en) * 1990-10-01 1992-04-28 Quinton Instrument Company Insertion assembly and method of inserting a vessel plug into the body of a patient
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5676689A (en) * 1991-11-08 1997-10-14 Kensey Nash Corporation Hemostatic puncture closure system including vessel location device and method of use
US6653291B1 (en) 1992-11-13 2003-11-25 Purdue Research Foundation Composition and method for production of transformed cells
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5601629A (en) * 1992-12-29 1997-02-11 Helbing; Clarence H. Apparatus for producing a fiberglass pack with two steps of binder application
US5902279A (en) 1993-04-20 1999-05-11 Advanced Cytometrix, Inc. Aspiration needle and method
WO1994026175A1 (en) * 1993-05-06 1994-11-24 Vitaphore Corporation Embolization device
DE69432148T2 (en) * 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
GB2282328B (en) * 1993-09-29 1997-10-08 Johnson & Johnson Medical Absorbable structures for ligament and tendon repair
US5480424A (en) * 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5460962A (en) 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
US5942496A (en) * 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US5489022A (en) 1994-04-19 1996-02-06 Sabin Corporation Ultraviolet light absorbing and transparent packaging laminate
ATE310839T1 (en) * 1994-04-29 2005-12-15 Scimed Life Systems Inc STENT WITH COLLAGEN
US6475232B1 (en) * 1996-12-10 2002-11-05 Purdue Research Foundation Stent with reduced thrombogenicity
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
JPH08196618A (en) * 1995-01-23 1996-08-06 Terumo Corp Cell invasive collagen formulation, artificial skin and their manufacture
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US5711969A (en) * 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6090063A (en) * 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
US6042605A (en) * 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
JP3337362B2 (en) * 1996-01-23 2002-10-21 テルモ株式会社 Collagen gel, collagen sheet and method for producing the same
US6024735A (en) * 1996-03-20 2000-02-15 Lifenet Research Foundation Process and composition for cleaning soft tissue grafts optionally attached to bone and soft tissue and bone grafts produced thereby
US5755791A (en) * 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US5788625A (en) * 1996-04-05 1998-08-04 Depuy Orthopaedics, Inc. Method of making reconstructive SIS structure for cartilaginous elements in situ
US5718012A (en) * 1996-05-28 1998-02-17 Organogenesis, Inc. Method of strength enhancement of collagen constructs
ES2208974T3 (en) * 1996-08-23 2004-06-16 Cook Biotech, Inc. PROTESIS OF GRAFT, MATERIALS AND METHODS.
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US5676146B1 (en) * 1996-09-13 2000-04-18 Osteotech Inc Surgical implant containing a resorbable radiopaque marker and method of locating such within a body
US5782914A (en) * 1996-11-29 1998-07-21 Bio-Vascular, Inc. Method for preparing heterogeneous tissue grafts
JP4084420B2 (en) * 1996-12-10 2008-04-30 パーデュー・リサーチ・ファウンデーション Tubular submucosa graft composition
CA2267310C (en) 1996-12-10 2012-09-18 Purdue Research Foundation Stomach submucosa derived tissue graft
CA2273250C (en) * 1996-12-10 2008-01-29 Cook Biotech, Inc. Stent grafts containing purified submucosa
CA2274082A1 (en) 1996-12-10 1998-06-18 Purdue Research Foundation Gastric submucosal tissue as a novel diagnostic tool
EP0942739B1 (en) 1996-12-10 2006-04-12 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6048362A (en) * 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
WO1999044538A1 (en) * 1998-01-27 1999-09-10 The Regents Of The University Of California Biodegradable polymer/protein based coils for intralumenal implants
EP1056836B1 (en) * 1998-02-27 2009-02-18 Purdue Research Foundation Submucosa gel compositions
US6187024B1 (en) * 1998-11-10 2001-02-13 Target Therapeutics, Inc. Bioactive coating for vaso-occlusive devices

Also Published As

Publication number Publication date
EP1985320B1 (en) 2017-06-21
JP2002531181A (en) 2002-09-24
EP1985320A1 (en) 2008-10-29
CA2319443C (en) 2009-09-29
ATE301478T1 (en) 2005-08-15
AU4316399A (en) 2000-06-19
DE69939370D1 (en) 2008-10-02
CA2319443A1 (en) 2000-06-08
US9089626B2 (en) 2015-07-28
DK1051206T3 (en) 2008-11-24
EP1051207B1 (en) 2005-08-10
EP1051206A1 (en) 2000-11-15
EP1051206B1 (en) 2008-08-20
US20100204782A1 (en) 2010-08-12
CA2319446C (en) 2010-09-14
US7713552B2 (en) 2010-05-11
WO2000032253A1 (en) 2000-06-08
WO2000032250A1 (en) 2000-06-08
US20030206860A1 (en) 2003-11-06
BR9908043A (en) 2001-12-18
EP1051207A1 (en) 2000-11-15
DE69926604D1 (en) 2005-09-15
AU1826700A (en) 2000-06-19

Similar Documents

Publication Publication Date Title
CA2319446A1 (en) Radiopaque implantable collagenous biomaterial device
CA2446573A1 (en) Surgical implant containing a resorbable radiopaque marker
Katou et al. Immuno-inflammatory responses in the tissue adjacent to titanium miniplates used in the treatment of mandibular fractures
EP1696978B1 (en) Radio-opaque marker for medical implants
EP1562565B1 (en) Use of one or more elements from the group containing yttrium, neodymium and zirconium
Barton et al. Embolization of bone metastases
Suuronen Biodegradable fracture-fixation devices in maxillofacial surgery
US7879367B2 (en) Metallic implant which is degradable in vivo
Sˇmahel Histology of the capsules causing constrictive fibrosis around breast implants
CA2319447A1 (en) Embolization device
AU1692897A (en) Compressed patient narrative storage in and full text reconstruction from implantable medical devices
CA2261044A1 (en) Surgical implants and delivery systems therefor
EP2374484A3 (en) Methods for embolizing blood vessels
AU655187B2 (en) Continuous release pharmaceutical compositions
EP0875217A3 (en) Method of manufacturing a medicated porous metal prosthesis
EP0875218A3 (en) Porous medicated stent
CA2304495A1 (en) Non-thrombogenic stent jacket
CA2185789A1 (en) Soft tissue closure systems
EP0819411A3 (en) Self-expanding stent delivery system
Gerlach In-vivo and clinical evaluations of poly (L-lactide) plates and screws for use in maxillofacial traumatology
Srouji et al. Bone defect repair in rat tibia by TGF-β1 and IGF-1 released from hydrogel scaffold
Berder et al. Retrieval of a lost coronary stent from the descending aorta using a PTCA balloon and biopsy forceps
Lasserre et al. Ceramic drug-delivery devices
Liu et al. Nitinol alloy endotracheal stent for treatment of tracheal stenosis
Hinman et al. Autogenous perineal bone graft for post-prostatectomy incontinence. II. Technique and results of prosthetic fixation of urogenital diaphragm in man

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20121122